620 related articles for article (PubMed ID: 17018806)
1. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
2. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
Myung W; Lim SW; Kim S; Kim H; Chung JW; Seo MY; Kim JW; Carroll BJ; Kim DK
Psychopharmacology (Berl); 2013 Jan; 225(2):283-90. PubMed ID: 22885912
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine and serotonin transporter genes: impact on treatment response in depression.
Baffa A; Hohoff C; Baune BT; Müller-Tidow C; Tidow N; Freitag C; Zwanzger P; Deckert J; Arolt V; Domschke K
Neuropsychobiology; 2010; 62(2):121-31. PubMed ID: 20588071
[TBL] [Abstract][Full Text] [Related]
5. SERT and NET polymorphisms, temperament and antidepressant response.
Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
[TBL] [Abstract][Full Text] [Related]
6. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
7. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Higuchi H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
[TBL] [Abstract][Full Text] [Related]
8. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
Manoharan A; Shewade DG; Rajkumar RP; Adithan S
Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
[TBL] [Abstract][Full Text] [Related]
10. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
Dreimüller N; Tadić A; Dragicevic A; Boland K; Bondy B; Lieb K; Laux G; Maier W; Müller MJ; Rao ML; Rietschel M; Röschke J; Zill P; Hiemke C
Pharmacopsychiatry; 2012 May; 45(3):108-13. PubMed ID: 22086748
[TBL] [Abstract][Full Text] [Related]
11. Potential involvement of NET polymorphism in serotonin/norepinephrine reuptake inhibitor response in panic disorder.
Park HJ; Kim SK; Kang WS; Kim YJ; Cho AR; Park JK
Nord J Psychiatry; 2016; 70(4):314-7. PubMed ID: 26508020
[TBL] [Abstract][Full Text] [Related]
12. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
[TBL] [Abstract][Full Text] [Related]
13. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.
Yu YW; Tsai SJ; Chen TJ; Lin CH; Hong CJ
Mol Psychiatry; 2002; 7(10):1115-9. PubMed ID: 12476327
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.
Silva H; Iturra P; Solari A; Villarroel J; Jerez S; Jiménez M; Galleguillos F; Bustamante ML
Psychiatr Genet; 2010 Feb; 20(1):25-30. PubMed ID: 20010449
[TBL] [Abstract][Full Text] [Related]
15. Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation.
Safarinejad MR
BJU Int; 2010 Jan; 105(1):73-8. PubMed ID: 19549114
[TBL] [Abstract][Full Text] [Related]
16. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter gene polymorphisms and sertraline response in major depression patients.
Dogan O; Yuksel N; Ergun MA; Yilmaz A; Ilhan MN; Karslioglu HE; Koc A; Menevse A
Genet Test; 2008 Jun; 12(2):225-31. PubMed ID: 18452396
[TBL] [Abstract][Full Text] [Related]
18. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
Zhu J; Klein-Fedyshin M; Stevenson JM
Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter gene polymorphism and antidepressant response.
Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]